» Articles » PMID: 32712030

Elevated Exosomal Secretion of MiR-124-3p from Spinal Neurons Positively Associates with Disease Severity in ALS

Overview
Journal Exp Neurol
Specialty Neurology
Date 2020 Jul 27
PMID 32712030
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRs) are powerful regulators of CNS development and diseases. Plasma and cerebrospinal fluid (CSF) miRs have recently been implicated as potential new sources for biomarker development. Previously we showed that miR-124-3p, an essential miR for neuronal identity, is highly abundant in neuronal exosomes and its expression decreases in spinal cord of ALS model SOD1G93A mice. In the current study, we found a disease associated reduction of miR-124-3p levels specifically in spinal neurons using in situ hybridization. By employing our recently developed exosome reporter mice in combination with sciatic nerve injections, we observed an increased association of miR-124-3p with spinal motor neuron-derived exosomes in SOD1G93A mice, even at the pre-symptomatic stage. Sciatic nerve injection delivered miR-124-3p is also more frequently localized outside of spinal motor neurons in SOD1G93A mice. Subsequent quantitative analysis of miR-124-3p levels in CSF exosomes from ALS patients found a significant correlation between CSF exosomal miR-124-3p levels and disease stage (indicated by the ALSFRS-R score) of (male) ALS patients. These results provide preliminary evidence to support the potential use of CSF exosomal miR-124-3p as a disease stage indicator in ALS.

Citing Articles

Exosome Cargo in Neurodegenerative Diseases: Leveraging Their Intercellular Communication Capabilities for Biomarker Discovery and Therapeutic Delivery.

Zhang S, Yang Y, Lv X, Zhou X, Zhao W, Meng L Brain Sci. 2024; 14(11).

PMID: 39595812 PMC: 11591915. DOI: 10.3390/brainsci14111049.


Exploring dysregulated miRNAs in ALS: implications for disease pathogenesis and early diagnosis.

Maity D, Kaundal R Neurol Sci. 2024; .

PMID: 39570437 DOI: 10.1007/s10072-024-07840-x.


New perspectives of the role of skeletal muscle derived extracellular vesicles in the pathogenesis of amyotrophic lateral sclerosis: the 'dying back' hypothesis.

Sbarigia C, Rome S, Dini L, Tacconi S J Extracell Biol. 2024; 3(11):e70019.

PMID: 39534483 PMC: 11555536. DOI: 10.1002/jex2.70019.


miR-124 coordinates metabolic regulators acting at early stages of human neurogenesis.

Son G, Na Y, Kim Y, Son J, Clemenson G, Schafer S Commun Biol. 2024; 7(1):1393.

PMID: 39455851 PMC: 11511827. DOI: 10.1038/s42003-024-07089-2.


Extracellular Vesicles: The Next Generation of Biomarkers and Treatment for Central Nervous System Diseases.

Zanirati G, Dos Santos P, Alcara A, Bruzzo F, Ghilardi I, Wietholter V Int J Mol Sci. 2024; 25(13).

PMID: 39000479 PMC: 11242541. DOI: 10.3390/ijms25137371.


References
1.
Rider M, Hurwitz S, Meckes Jr D . ExtraPEG: A Polyethylene Glycol-Based Method for Enrichment of Extracellular Vesicles. Sci Rep. 2016; 6:23978. PMC: 4828635. DOI: 10.1038/srep23978. View

2.
Koval E, Shaner C, Zhang P, du Maine X, Fischer K, Tay J . Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice. Hum Mol Genet. 2013; 22(20):4127-35. PMC: 3781640. DOI: 10.1093/hmg/ddt261. View

3.
Men Y, Yelick J, Jin S, Tian Y, Chiang M, Higashimori H . Exosome reporter mice reveal the involvement of exosomes in mediating neuron to astroglia communication in the CNS. Nat Commun. 2019; 10(1):4136. PMC: 6742670. DOI: 10.1038/s41467-019-11534-w. View

4.
Butovsky O, Jedrychowski M, Cialic R, Krasemann S, Murugaiyan G, Fanek Z . Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice. Ann Neurol. 2014; 77(1):75-99. PMC: 4432483. DOI: 10.1002/ana.24304. View

5.
Chen X, Shang H . New developments and future opportunities in biomarkers for amyotrophic lateral sclerosis. Transl Neurodegener. 2015; 4:17. PMC: 4589120. DOI: 10.1186/s40035-015-0040-2. View